Search

Your search keyword '"Mandarakas, Melissa R"' showing total 13 results
Start Over Author "Mandarakas, Melissa R"
13 results on '"Mandarakas, Melissa R"'

2. Diagnosis and management of Guillain–Barré syndrome in ten steps

Author

Leonhard, Sonja E., Mandarakas, Melissa R., Gondim, Francisco A. A., Bateman, Kathleen, Ferreira, Maria L. B., Cornblath, David R., van Doorn, Pieter A., Dourado, Mario E., Hughes, Richard A. C., Islam, Badrul, Kusunoki, Susumu, Pardo, Carlos A., Reisin, Ricardo, Sejvar, James J., Shahrizaila, Nortina, Soares, Cristiane, Umapathi, Thirugnanam, Wang, Yuzhong, Yiu, Eppie M., Willison, Hugh J., and Jacobs, Bart C.

Published
2019
Full Text
View/download PDF

4. Guía basada en la evidencia. Diagnóstico y manejo del síndrome de Guillain-Barré en diez pasos = Evidence based guidelines. Diagnosis and management of Guillain-Barré syndrome in ten steps

Author

Leonhard, Sonja E., Mandarakas, Melissa R., de Assis Aquino Gondim, Francisco, Bateman, Kathleen, Brito Ferreira, Maria L., Cornblath, David R., Van Doorn, Pieter A., Dourado, Mario E., Hughes, Richard A.C., Islam, Badrul, Kusunoki, Susumu, Pardo, Carlos A., Reisin, Ricardo, Sejvar, James J., Shahrizaila, Nortina, Soares, Cristiane, Umapathi, Thirugnanam, Wang, Yuzhong, Yiu, Eppie M., Willison, Hugh J., and Jacobs, Bart C.

Abstract

Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and in 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae.

Published
2021

6. Diretrizes Baseadas em Evidências Diagnóstico e manejo da Síndrome de Guillain–Barré em dez etapas

Author

Leonhard, Sonja E., primary, Mandarakas, Melissa R., additional, Gondim, Francisco A.A., additional, Bateman, Kathleen, additional, Ferreira, Maria L.B., additional, Cornblath, David R., additional, Van Doorn, Pieter A., additional, Dourado, Mario E., additional, Hughes, Richard A.C., additional, Islam, Badrul, additional, Kusunoki, Susumu, additional, Pardo, Carlos A., additional, Reisin, Ricardo, additional, Sejvar, James J., additional, Shahrizaila, Nortina, additional, Soares, Cristiane, additional, Umapathi, Thirugnanam, additional, Wang, Yuzhong, additional, Yiu, Eppie M., additional, Willison, Hugh J., additional, and Jacobs, Bart C., additional

Published
2021
Full Text
View/download PDF

7. GUÍA BASADA EN LA EVIDENCIA. DIAGNÓSTICO Y MANEJO DEL SÍNDROME DE GUILLAIN-BARRÉ EN DIEZ PASOS.

Author

LEONHARD, SONJA E., MANDARAKAS, MELISSA R., DE ASSIS AQUINO GONDIM, FRANCISCO, BATEMAN, KATHLEEN, BRITO FERREIRA, MARIA L., CORNBLATH, DAVID R., VAN DOORN, PIETER A., DOURADO, MARIO E., HUGHES, RICHARD A. C., ISLAM, BADRUL, SUSUMU KUSUNOKI, PARDO, CARLOS A., REISIN, RICARDO, SEJVAR, JAMES J., SHAHRIZAILA, NORTINA, SOARES, CRISTIANE, UMAPATHI, THIRUGNANAM, YUZHONG WANG, YIU, EPPIE M., and WILLISON, HUGH J.

Abstract

Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2021

8. Erratum to: Development and validation of the Charcot-Marie-Tooth Disease Infant Scale

Author

Mandarakas, Melissa R, primary, Menezes, Manoj P, additional, Rose, Kristy J, additional, Shy, Rosemary, additional, Eichinger, Kate, additional, Foscan, Maria, additional, Estilow, Timothy, additional, Kennedy, Rachel, additional, Herbert, Karen, additional, Bray, Paula, additional, Refshauge, Kathryn, additional, Ryan, Monique M, additional, Yiu, Eppie M, additional, Farrar, Michelle, additional, Sampaio, Hugo, additional, Moroni, Isabella, additional, Pagliano, Emanuela, additional, Pareyson, Davide, additional, Yum, Sabrina W, additional, Herrmann, David N, additional, Acsadi, Gyula, additional, Shy, Michael E, additional, Burns, Joshua, additional, and Sanmaneechai, Oranee, additional

Published
2019
Full Text
View/download PDF

9. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale

Author

Mandarakas, Melissa R, primary, Menezes, Manoj P, additional, Rose, Kristy J, additional, Shy, Rosemary, additional, Eichinger, Kate, additional, Foscan, Maria, additional, Estilow, Timothy, additional, Kennedy, Rachel, additional, Herbert, Karen, additional, Bray, Paula, additional, Refshauge, Kathryn, additional, Ryan, Monique M, additional, Yiu, Eppie M, additional, Farrar, Michelle, additional, Sampaio, Hugo, additional, Moroni, Isabella, additional, Pagliano, Emanuela, additional, Pareyson, Davide, additional, Yum, Sabrina W, additional, Herrmann, David N, additional, Acsadi, Gyula, additional, Shy, Michael E, additional, Burns, Joshua, additional, and Sanmaneechai, Oranee, additional

Published
2018
Full Text
View/download PDF

11. Safety and efficacy of progressive resistance exercise for Charcot-Marie-Tooth disease in children: a randomised, double-blind, sham-controlled trial

Author

Burns, Joshua, primary, Sman, Amy D, additional, Cornett, Kayla M D, additional, Wojciechowski, Elizabeth, additional, Walker, Terri, additional, Menezes, Manoj P, additional, Mandarakas, Melissa R, additional, Rose, Kristy J, additional, Bray, Paula, additional, Sampaio, Hugo, additional, Farrar, Michelle, additional, Refshauge, Kathryn M, additional, Raymond, Jacqueline, additional, Burns, Joshua, additional, Baldwin, Jennifer, additional, McKay, Marnee J, additional, Mudge, Anita, additional, Purcell, Leanne, additional, Miller, Clare, additional, Gray, Kelly, additional, Harman, Meghan, additional, Gabrael, Natalie, additional, and Ouvrier, Robert A, additional

Published
2017
Full Text
View/download PDF

12. Magnetic resonance imaging of the anterior compartment of the lower leg is a biomarker for weakness, disability, and impaired gait in childhood Charcot-Marie-Tooth disease.

Author

Cornett, Kayla M. D., Wojciechowski, Elizabeth, Sman, Amy D., Walker, Terri, Menezes, Manoj P., Bray, Paula, Halaki, Mark, Burns, Joshua, Sman, D., Mandarakas, Melissa R., Rose, Kristy J., Baldwin, Jennifer, McKay, Marnee J., Refshauge, Kathryn M., Raymond, Jacqueline, Sampaio, Hugo, Mudge, Anita, Purcell, Leanne, Miller, Clare, and Gray, Kelly

Subjects
CHARCOT-Marie-Tooth disease, COMPARATIVE studies, GAIT disorders, DIGITAL image processing, LEG, MAGNETIC resonance imaging, RESEARCH methodology, MEDICAL cooperation, MUSCLE strength, NEUROLOGICAL disorders, PEOPLE with disabilities, RESEARCH, EVALUATION research, SKELETAL muscle, MUSCLE weakness, DISEASE complications
Abstract

Introduction: Biomarkers of disease severity in Charcot-Marie-Tooth disease (CMT) are required to evaluate early responses to treatment. In this study we used magnetic resonance imaging (MRI) to evaluate the relationship between muscle volume and intramuscular fat accumulation with weakness, disability, and impaired gait in affected children and adolescents.Methods: Fifty-five participants underwent MRI of the anterior compartment of the lower leg. Muscle and fat volumes were calculated. Strength was measured using hand-held dynamometry, disability using the CMT Pediatric Scale, and 3-dimensional gait analysis using an 8-camera Vicon Nexus motion capture system.Results: Lower muscle volume was significantly associated with reduced dorsiflexion strength, increased disability, impaired gait profile score, and foot drop. Intramuscular fat accumulation was associated with reduced dorsiflexion strength and impaired gait profile score.Discussion: The MRI protocol described was feasible, reliable, and sensitive to the magnitude of weakness, disability, and walking difficulties in children with CMT. Muscle Nerve 59:213-217, 2019. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

13. [Evidence based guidelines. Diagnosis and management of Guillain-Barré syndrome in ten steps].

Author

Leonhard SE, Mandarakas MR, de Assis Aquino Gondim F, Bateman K, Brito Ferreira ML, Cornblath DR, Van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, and Jacobs BC

Subjects
Disease Outbreaks, Humans, Incidence, Guillain-Barre Syndrome diagnosis, Guillain-Barre Syndrome epidemiology, Guillain-Barre Syndrome therapy, Zika Virus, Zika Virus Infection diagnosis, Zika Virus Infection epidemiology, Zika Virus Infection therapy
Abstract

Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and in 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available. To support clinicians, especially in the context of an outbreak, we have developed a globally applicable guideline for the diagnosis and management of GBS. The guideline is based on current literature and expert consensus, and has a ten-step structure to facilitate its use in clinical practice. We first provide an introduction to the diagnostic criteria, clinical variants and differential diagnoses of GBS. The ten steps then cover early recognition and diagnosis of GBS, admission to the intensive care unit, treatment indication and selection, monitoring and treatment of disease progression, prediction of clinical course and outcome, and management of complications and sequelae.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results